pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    testosterone enanthate
    Xyosted (testosterone enanthate)
    Secondary (Hypogonadotropic) Hypogonadism Antares Pharma Inc
  • Preclinical
    tetraiodothyroacetic acid
    Glioblastoma Multiforme (GBM) NanoPharmaceuticals LLC
  • Preclinical
    tezacitabine
    tezacitabine
    Hematological Tumor Edison Oncology Holding Corp
  • Preclinical
← prev
page 59 of 62
next →
Pain89
Neurology1
thalidomide
Taldo (thalidomide)
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu…
PlumeStars Srl
  • Marketed
    thioguanine
    Thioguanine
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Woodward Pharma Services LLC
  • Marketed
    thiotepa
    Thiotepa (thiotepa [INN])
    Breast Cancer STI Pharma LLC
  • Phase 3
    tifcemalimab
    tifcemalimab [INN]
    Small-Cell Lung Cancer Shanghai Junshi Biosciences Co Ltd
  • Phase 2
    tigilanol tiglate
    tigilanol tiglate
    Angiosarcoma QBiotics Group Ltd
  • Phase 3
    tinengotinib
    tinengotinib
    Bile Duct Cancer (Cholangiocarcinoma) TransThera Sciences (Nanjing) Inc
  • Phase 3
    tinostamustine
    tinostamustine
    Recurrent Glioblastoma Multiforme (GBM) Mundipharma EDO GmbH
  • Phase 3
    tipifarnib
    tipifarnib
    Peripheral T-Cell Lymphomas (PTCL)$KURA Kura Oncology, Inc.
  • pre_registration
    tirabrutinib hydrochloride
    tirabrutinib hydrochloride
    Primary CNS Lymphoma Ono Pharmaceutical Co Ltd
  • Phase 2
    tirapazamine
    tirapazamine
    Colorectal Cancer Teclison Ltd
  • Marketed
    tisagenlecleucel
    Kymriah (tisagenlecleucel)
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$NVS NOVARTIS AG
  • Marketed
    tivozanib hydrochloride
    Fotivda (tivozanib hydrochloride)
    Metastatic Renal Cell Carcinoma AVEO Pharmaceuticals Inc
  • Phase 1
    tolododekin alfa
    tolododekin alfa
    Cutaneous Squamous Cell Carcinoma (cSCC) Ankyra Therapeutics Inc
  • Phase 2
    topotecan
    HYCAMTIN (topotecan [INN])
    Retinoblastoma Targeted Therapy Technologies LLC
  • Phase 2
    tosposertib
    tosposertib [INN]
    Solid Tumor TiumBio Co Ltd
  • Phase 3
    tovecimig
    tovecimig [INN]
    Bile Duct Cancer (Cholangiocarcinoma)$COMP Compass, Inc.
  • Phase 2
    toviblideg
    toviblideg
    Follicular Lymphoma Bristol-Myers Squibb Co
  • Marketed
    tovorafenib
    Ojemda (tovorafenib)
    Low-Grade Glioma$DAWN Day One Biopharmaceuticals, Inc.
  • Marketed
    trabectedin
    Trabectedin
    Ewing Sarcoma$JNJ JOHNSON & JOHNSON
  • Phase 2
    trabedersen
    Oncomun (trabedersen [INN])
    Metastatic Melanoma Sapu Bioscience LLC
  • Marketed
    trastuzumab
    Herceptin (trastuzumab)
    Adenocarcinoma Of The Gastroesophageal Junction Genentech Inc
  • pre_registration
    trastuzumab biosimilar
    Hercessi (trastuzumab-strf)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… EirGenix Inc
  • Phase 3
    trastuzumab pamirtecan
    trastuzumab pamirtecan
    Endometrial Cancer$BNTX BioNTech SE
  • Marketed
    tretinoin
    Tretinoin Mylan (tretinoin)
    Acne Vulgaris Mylan Pharmaceuticals Inc
  • Phase 2
    trevotamig
    trevotamig [INN]
    Adenocarcinoma$BCAB BioAtla, Inc.
  • Marketed
    trilaciclib
    Cosela (trilaciclib)
    Triple-Negative Breast Cancer (TNBC) Pharmacosmos AS
  • Phase 2
    trovostobart
    trovostobart [INN]
    Bladder Cancer TuHURA Biosciences Inc